23 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 35389901 | Decreased Ankyrin Expression Is Associated with Repressed eNOS Signaling, Cell Proliferation, and Osteogenic Differentiation in Osteonecrosis of the Femoral Head. | 2022 Apr 6 | 1 |
2 | 33024087 | CD44/HA signaling mediates acquired resistance to a PI3Kα inhibitor. | 2020 Oct 6 | 2 |
3 | 33102192 | Induction of apoptosis and role of paclitaxel-loaded hyaluronic acid-crosslinked nanoparticles in the regulation of AKT and RhoA. | 2020 Jul-Sep | 1 |
4 | 33736281 | Hyaluronic acid injection reduces inflammatory and apoptotic markers through modulation of AKT by repressing the oxidative status of neutrophils from osteoarthritic synovial fluid. | 2020 Dec 15 | 2 |
5 | 29664021 | A TLR/AKT/FoxO3 immune tolerance-like pathway disrupts the repair capacity of oligodendrocyte progenitors. | 2018 May 1 | 1 |
6 | 26210045 | Hyaluronan carried by tumor-derived microvesicles induces IL-10 production in classical (CD14++CD16-) monocytes via PI3K/Akt/mTOR-dependent signalling pathway. | 2017 Jan | 1 |
7 | 28533273 | Akt Signaling Is Sustained by a CD44 Splice Isoform-Mediated Positive Feedback Loop. | 2017 Jul 15 | 1 |
8 | 25738334 | 20-O-β-D-glucopyranosyl-20(S)-protopanaxadiol, a metabolite of ginsenoside Rb1, enhances the production of hyaluronic acid through the activation of ERK and Akt mediated by Src tyrosin kinase in human keratinocytes. | 2015 May | 1 |
9 | 24942858 | Type II collagen peptide stimulates Akt leading to nuclear factor-κB activation: its inhibition by hyaluronan. | 2014 | 1 |
10 | 23806178 | Hyaluronan up-regulates growth and invasion of trophoblasts in an autocrine manner via PI3K/AKT and MAPK/ERK1/2 pathways in early human pregnancy. | 2013 Sep | 1 |
11 | 22451658 | Overexpression of hyaluronan-binding protein 1 (HABP1/p32/gC1qR) in HepG2 cells leads to increased hyaluronan synthesis and cell proliferation by up-regulation of cyclin D1 in AKT-dependent pathway. | 2012 Jun 1 | 1 |
12 | 22825838 | Melanoma cell-derived factors stimulate hyaluronan synthesis in dermal fibroblasts by upregulating HAS2 through PDGFR-PI3K-AKT and p38 signaling. | 2012 Dec | 1 |
13 | 21422731 | Hyaluronan inhibits Akt, leading to nuclear factor-κB down-regulation in lipopolysaccharide-stimulated U937 macrophages. | 2011 | 1 |
14 | 21673451 | Activation of Akt leading to NF-κB up-regulation in chondrocytes stimulated with fibronectin fragment. | 2011 Jun | 2 |
15 | 20501660 | Methyl-beta-cyclodextrin suppresses hyaluronan synthesis by down-regulation of hyaluronan synthase 2 through inhibition of Akt. | 2010 Jul 23 | 1 |
16 | 18326857 | Hyaluronan constitutively regulates activation of COX-2-mediated cell survival activity in intestinal epithelial and colon carcinoma cells. | 2008 May 23 | 2 |
17 | 18577517 | CD44-epidermal growth factor receptor interaction mediates hyaluronic acid-promoted cell motility by activating protein kinase C signaling involving Akt, Rac1, Phox, reactive oxygen species, focal adhesion kinase, and MMP-2. | 2008 Aug 15 | 1 |
18 | 16461453 | Hyaluronan oligosaccharides induce cell death through PI3-K/Akt pathway independently of NF-kappaB transcription factor. | 2006 May | 2 |
19 | 15705860 | Hyaluronic acid induces osteopontin via the phosphatidylinositol 3-kinase/Akt pathway to enhance the motility of human glioma cells. | 2005 Feb 1 | 1 |
20 | 15784621 | Regulation of MDR1 expression and drug resistance by a positive feedback loop involving hyaluronan, phosphoinositide 3-kinase, and ErbB2. | 2005 May 27 | 1 |
21 | 16153533 | The hyaluronan-binding protease upregulates ERK1/2 and PI3K/Akt signalling pathways in fibroblasts and stimulates cell proliferation and migration. | 2005 Dec | 1 |
22 | 12145277 | Hyaluronan oligosaccharides inhibit anchorage-independent growth of tumor cells by suppressing the phosphoinositide 3-kinase/Akt cell survival pathway. | 2002 Oct 11 | 2 |
23 | 11408591 | Hyaluronan activates cell motility of v-Src-transformed cells via Ras-mitogen-activated protein kinase and phosphoinositide 3-kinase-Akt in a tumor-specific manner. | 2001 Jun | 1 |